Literature DB >> 29305985

Mechanistic studies of the antibiofilm activity and synergy with antibiotics of isosorbide mononitrate.

Sayeed Hasan1, Yassamin N S Albayaty1, Benjamin Thierry2, Clive A Prestidge3, Nicky Thomas4.   

Abstract

The use of nitric oxide (NO), a naturally occurring antimicrobial agent, as an alternative strategy to combat bacterial biofilms has recently gained considerable momentum in light of the global threat of emerging antibiotic resistance. While previous NO-based anti-biofilm approaches were aimed at killing bacterial cells within biofilms, NO has also been recently identified as a key mediator of biofilm dispersal, causing the release of cells from the biofilm community. This is of great interest towards the design of more effective anti-biofilm strategies but further studies are warranted to validate this concept. Therefore, in the present study we investigated whether a NO precursor, isosorbide mononitrate (ISMN) or its analogue D-isosorbide can induce bacteria cell dispersal from Staphylococcus aureus (S. aureus) biofilms and explored the potential synergy of ISMN and the antimicrobial compounds mupirocin and ciprofloxacin in biofilm eradication. This study demonstrate that ISMN causes dispersal of S. aureus biofilm bacteria, particularly when exposed to high levels of drug. ISMN at 60mg/mL increased the number of colony forming units (CFU) (~3log10 and ~5log10) of planktonic bacteria after 6 and 24-h exposure respectively, compared to control biofilms. This suggests that ISMN induces the transition of sessile biofilm cells to free-swimming planktonic cells. In addition, ISMN exhibits synergistic effects against S. aureus biofilms with ciprofloxacin when tested above its minimum inhibitory concentration (MIC). Specifically, exposure to ISMN significantly enhanced the efficacy of ciprofloxacin by reducing the number of CFU (~3log10 or ~2log10) of biofilm-associated and planktonic bacteria respectively, compared to drug alone. Combined exposure to both ISMN and certain antimicrobial agents may therefore offer an innovative approach to control persistent biofilm and biofilm-associated infections.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibacterial effect; Biofilm; Biofilm-associated infection; Isosorbide mononitrate; Nitric oxide; Nitric oxide precursor; Staphylococcus aureus

Mesh:

Substances:

Year:  2018        PMID: 29305985     DOI: 10.1016/j.ejps.2018.01.003

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  4 in total

Review 1.  Nitric oxide for the prevention and treatment of viral, bacterial, protozoal and fungal infections.

Authors:  Philip M Bath; Christopher M Coleman; Adam L Gordon; Wei Shen Lim; Andrew J Webb
Journal:  F1000Res       Date:  2021-07-05

Review 2.  NO donors and NO delivery methods for controlling biofilms in chronic lung infections.

Authors:  Yu-Ming Cai; Ying-Dan Zhang; Liang Yang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-03       Impact factor: 5.560

Review 3.  Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications.

Authors:  Wee Han Poh; Scott A Rice
Journal:  Molecules       Date:  2022-01-20       Impact factor: 4.411

4.  The Relationship between Compound Danshen Dripping Pills with Isosorbide Mononitrate in the Treatment of Elderly Patients with Unstable Angina Pectoris.

Authors:  Yulin Liang; Junbo Zou; Xiaofei Zhang; Yu Wang; Jia Tai; Dongyan Guo; Chunli Cui; Jing Wang; Jiangxue Cheng; Yajun Shi
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-18       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.